Soligenix (SNGX) vs Universe Pharmaceuticals (UPC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Universe Pharmaceuticals is the larger company by market cap ($5.4 million vs $5.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SNGX | UPC |
|---|---|---|
| Share price | $0.2201 | $1.08 |
| Market cap | $5.14M | $5.43M |
| 1-day change | -8.29% | -20.59% |
| YTD return | — | -71.65% |
| 1-year return | — | -68.24% |
| 5-year return | — | -99.99% |
| EPS (TTM) | $-0.21 | $-1.38 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $17.86B |
| Revenue growth (YoY) | — | -22.44% |
| Net income (latest FY) | $-11.08M | $-3.67B |
| Gross margin | — | 35.28% |
| Operating margin | — | -16.33% |
| Net margin | — | -20.56% |
| 52-week high | $1.70 | $17.96 |
| 52-week low | $0.21 | $1.05 |
| Distance from 52-week high | -87.05% | -93.99% |
| Analyst consensus | none | — |
| Avg. price target upside | +526.99% | — |
| Average volume | 198.15K | 176.76K |
| Shares outstanding | 23.37M | 5.01M |
| Employees | 13 | 216 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Soligenix
SNGX stock →Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions.
Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees
About Universe Pharmaceuticals
UPC stock →Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.
Health Care · Biotechnology: Pharmaceutical Preparations · 216 employees
SNGX vs UPC FAQ
Which is bigger, Soligenix or Universe Pharmaceuticals?
Universe Pharmaceuticals (UPC) is larger, with a market capitalization of $5.43M compared with $5.14M for Soligenix (SNGX).
Are Soligenix and Universe Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.